Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.38 Million ≈ $17.18 Million USD) by net assets (CN¥15.04 Billion ≈ $2.20 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhangzhou Pientzehuang Pharmaceutical Co (600436) balance sheet quality index to measure how much of total assets are equity-financed.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhangzhou Pientzehuang Pharmaceutical Co cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhangzhou Pientzehuang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Samsung SDS Co Ltd
KO:018260
|
0.033x |
|
Align Technology Inc
NASDAQ:ALGN
|
0.036x |
|
Carrefour SA
PA:CA
|
0.366x |
|
Phison Electronics
TWO:8299
|
0.036x |
|
BUREAU VERITAS ADR EO-12
F:4BV0
|
N/A |
|
Renaissancere Holdings Ltd
NYSE:RNR
|
0.037x |
|
MAPFRE S.A.ADR 2 / EO-10
F:CMA
|
N/A |
|
Texas Roadhouse Inc
NASDAQ:TXRH
|
0.097x |
Annual Cash Flow Conversion Efficiency for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Zhangzhou Pientzehuang Pharmaceutical Co market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥15.09 Billion ≈ $2.21 Billion |
CN¥77.03 Million ≈ $11.27 Million |
0.005x | -94.23% |
| 2024-12-31 | CN¥14.84 Billion ≈ $2.17 Billion |
CN¥1.31 Billion ≈ $192.24 Million |
0.089x | -44.15% |
| 2023-12-31 | CN¥13.92 Billion ≈ $2.04 Billion |
CN¥2.21 Billion ≈ $322.90 Million |
0.159x | -72.73% |
| 2022-12-31 | CN¥11.82 Billion ≈ $1.73 Billion |
CN¥6.87 Billion ≈ $1.01 Billion |
0.581x | +1174.64% |
| 2021-12-31 | CN¥10.14 Billion ≈ $1.48 Billion |
CN¥462.27 Million ≈ $67.64 Million |
0.046x | -74.33% |
| 2020-12-31 | CN¥8.26 Billion ≈ $1.21 Billion |
CN¥1.47 Billion ≈ $214.68 Million |
0.178x | +240.83% |
| 2019-12-31 | CN¥6.97 Billion ≈ $1.02 Billion |
CN¥-879.37 Million ≈ $-128.68 Million |
-0.126x | -209.37% |
| 2018-12-31 | CN¥5.31 Billion ≈ $776.67 Million |
CN¥612.31 Million ≈ $89.60 Million |
0.115x | -24.58% |
| 2017-12-31 | CN¥4.43 Billion ≈ $647.55 Million |
CN¥676.93 Million ≈ $99.06 Million |
0.153x | +45.43% |
| 2016-12-31 | CN¥3.75 Billion ≈ $548.85 Million |
CN¥394.54 Million ≈ $57.73 Million |
0.105x | +13.74% |
| 2015-12-31 | CN¥3.30 Billion ≈ $483.38 Million |
CN¥305.51 Million ≈ $44.71 Million |
0.092x | +4.45% |
| 2014-12-31 | CN¥2.99 Billion ≈ $437.14 Million |
CN¥264.50 Million ≈ $38.70 Million |
0.089x | -16.34% |
| 2013-12-31 | CN¥2.59 Billion ≈ $379.33 Million |
CN¥274.34 Million ≈ $40.14 Million |
0.106x | +1.37% |
| 2012-12-31 | CN¥1.56 Billion ≈ $227.63 Million |
CN¥162.40 Million ≈ $23.76 Million |
0.104x | -46.71% |
| 2011-12-31 | CN¥1.19 Billion ≈ $173.99 Million |
CN¥232.95 Million ≈ $34.09 Million |
0.196x | +3.38% |
| 2010-12-31 | CN¥1.08 Billion ≈ $158.60 Million |
CN¥205.41 Million ≈ $30.06 Million |
0.190x | +25.43% |
| 2009-12-31 | CN¥857.19 Million ≈ $125.43 Million |
CN¥129.52 Million ≈ $18.95 Million |
0.151x | +803.81% |
| 2008-12-31 | CN¥752.09 Million ≈ $110.05 Million |
CN¥12.57 Million ≈ $1.84 Million |
0.017x | -78.87% |
| 2007-12-31 | CN¥758.85 Million ≈ $111.04 Million |
CN¥60.04 Million ≈ $8.79 Million |
0.079x | -3.09% |
| 2006-12-31 | CN¥621.09 Million ≈ $90.89 Million |
CN¥50.70 Million ≈ $7.42 Million |
0.082x | -28.12% |
| 2005-12-31 | CN¥608.07 Million ≈ $88.98 Million |
CN¥69.06 Million ≈ $10.11 Million |
0.114x | -37.95% |
| 2004-12-31 | CN¥539.08 Million ≈ $78.88 Million |
CN¥98.67 Million ≈ $14.44 Million |
0.183x | +213.15% |
| 2003-12-31 | CN¥553.59 Million ≈ $81.01 Million |
CN¥32.36 Million ≈ $4.73 Million |
0.058x | -91.42% |
| 2002-12-31 | CN¥154.81 Million ≈ $22.65 Million |
CN¥105.45 Million ≈ $15.43 Million |
0.681x | +51.06% |
| 2001-12-31 | CN¥146.02 Million ≈ $21.37 Million |
CN¥65.84 Million ≈ $9.63 Million |
0.451x | -- |
About Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Zhangzhou Pientzehuang Pharmaceutical., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemicals… Read more